Skip to content
Butterfly child being treated at the EB House Austria

Current Clinical trials in the EB House

The Study Centre in the EB House Austria is currently conducting several clinical trials.

Information on the ongoing trials can be found in the table below.

Due to the current Covid-19 pandemic some studies are on-hold. We will update this table regularly to keep you informed.

  INM-755 Cream Rigosertib
Application form cannabinol containing cream oral capsules / infusion

 (intrapatient controlled)



Applicable age

from 18 years

(from 12 years in later stages)

18-79 years
Special inclusion criteria
  • presence of paired wound or itching areas with certain size and age
  • no use of  other cannabis products
  • unresectable, locally advanced or metastatic squamous cell carcinoma
  • certain lab values within given ranges
Site visits 6 (3 of those can be carried out via home visit of study nurse ) + 1 phone call at end of trial 17-20 (interval 1-4 weeks, plus weekly telephone calls)


If you have any questions about individual studies or trials, please contact the study coordinator:


Sophie Kitzmüller, PhD

Study Coordinator
Back to main navigation